The recent legal victory by the Medicines and Healthcare products Regulatory Agency (MHRA) marks the conclusion of a harrowing, decade-long investigation into a grave breach of public trust. Kenneth George Harrison, 69, and his company, Medicina Limited, have been found guilty of fraud after deliberately bypassing the stringent safety standards designed to protect hospital patients. By supplying medical equipment—ranging from specialized feeding pumps for newborns to gastrostomy devices—with fraudulent certification, they essentially misled the NHS into deploying untested, potentially dangerous equipment across the UK.
At the heart of this case lies a series of systemic deceptions that put the most vulnerable, including critically ill newborn babies in intensive care, at unnecessary risk. These devices were sold with fake “CE” markings, which serve as a gold-standard safety guarantee in the medical community. Because the paperwork appeared legitimate, hospitals across the country trusted that these products had undergone rigorous safety testing and clinical evaluation. In reality, these items entered the market without any of the oversight required to ensure they were safe for human, let alone infant, use.
The MHRA’s investigation, which began in 2013, represents a painstaking effort to uncover a sophisticated web of criminality. Throughout the process, the agency had to act swiftly to pull these compromised devices from circulation, issuing safety alerts and recalls to remove them from hospitals. Their primary goal was always the preservation of human life, forcing out products that had been placed on the market through calculated deception rather than merit or safety compliance.
The human cost of this fraud is staggering when considering the fragile lives involved. James Pound, a director at the MHRA, emphasized that the agency will never compromise on patient safety, particularly when it involves defenseless newborns. The investigation confirmed that the defendants prioritized profit over the clinical necessity of proper, verified medical equipment. By selling unverified products, they turned a substantial profit while exploiting a healthcare system that fundamentally relies on the honesty of its suppliers.
Following the conviction, the Crown Prosecution Service (CPS) has made it clear that this level of dishonesty will not be ignored. Beyond the criminal convictions, authorities are now pursuing confiscation proceedings to seize any assets gained through this illegal activity—a clear message that criminal enterprises will not be allowed to benefit from endangering the public. The legal process is ongoing, with sentencing scheduled for late 2026, serving as a sobering reminder of the gravity of these crimes.
Ultimately, this case serves as a vital reminder of why regulatory oversight is a matter of life and death. The MHRA continues to urge the public and healthcare professionals to stay vigilant and report any suspected non-compliant devices through the “Yellow Card” scheme. While the legal system works to ensure that Harrison and Medicina Limited face the consequences of their actions, the legacy of this case remains a testament to the importance of integrity in medical supply chains and the agency’s unwavering commitment to keeping patients safe.